{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:10:26Z","timestamp":1784675426342,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:22:11Z","timestamp":1693581731000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ocular Sarcoidosis"],"prefix":"10.1016","volume":"45","author":[{"given":"James T.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirichai","family":"Pasadhika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ccm.2023.08.003_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2023.08.003_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2021.03.003","article-title":"Systemic associations of sarcoid uveitis: correlation with uveitis phenotype and ethnicity","volume":"229","author":"Niederer","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ccm.2023.08.003_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","article-title":"Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis","volume":"198","author":"Ma","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.003_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/medicina58070898","article-title":"Sarcoid uveitis: an intriguing challenger","volume":"58","author":"Allegri","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.003_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"Seve","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.003_bib6","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s00417-022-05701-x","article-title":"Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo","volume":"260","author":"Nagahori","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.003_bib7","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41433-021-01770-0","article-title":"Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population","volume":"36","author":"Reid","year":"2022","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.003_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjophthalmol-2016-309767","article-title":"Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis","volume":"101","author":"Rochepeau","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ccm.2023.08.003_bib9","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.2147\/OPTH.S278373","article-title":"Ocular manifestations of sarcoidosis in a south Florida population","volume":"14","author":"Laura","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.003_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/09273948.2022.2067067","article-title":"Changing trends in uveitis in the United Kingdom: 5000 consecutive referrals to a tertiary referral centre","volume":"31","author":"Jones","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ccm.2023.08.003_bib11","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1080\/09273948.2017.1313991","article-title":"The pattern of uveitis in Sri Lanka","volume":"25","author":"Siak","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ccm.2023.08.003_bib12","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1080\/09273948.2016.1247871","article-title":"Etiology and clinical features of ocular inflammatory diseases in a tertiary referral centre in sydney, Australia","volume":"25","author":"Zagora","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.ccm.2023.08.003_bib13","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1080\/09273948.2016.1188968","article-title":"The pattern of uveitis among Chinese, Malays, and Indians in Singapore","volume":"25","author":"Siak","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.003_bib15","first-page":"209","article-title":"Clinical characteristics of sarcoidosis patients in the United States versus China","volume":"34","author":"Ying","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12890-020-01191-x","article-title":"Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts","volume":"20","author":"Te","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib17","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1038\/s41598-018-27554-3","article-title":"Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan","volume":"8","author":"Hattori","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.003_bib18","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00417-019-04415-x","article-title":"Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis","volume":"257","author":"Coulon","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.ccm.2023.08.003_bib19","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1007\/s10792-020-01531-0","article-title":"Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements","volume":"40","author":"Dammacco","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.003_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2017.07.006","article-title":"Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients","volume":"125","author":"Acharya","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.003_bib22","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"7\u20138","key":"10.1016\/j.ccm.2023.08.003_bib23","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/09273948.2020.1758159","article-title":"A\u00a0validation study of the revised diagnostic criteria from the international workshop on ocular sarcoidosis at a single institute in Japan","volume":"29","author":"Handa-Miyauchi","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.003_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/bjophthalmol-2020-317354","article-title":"Recommendations for the management of ocular sarcoidosis from the international workshop on ocular sarcoidosis","volume":"105","author":"Takase","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ccm.2023.08.003_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","article-title":"Classification criteria for sarcoidosis-associated uveitis","volume":"228","author":"Standardization of Uveitis Nomenclature Working","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib26","doi-asserted-by":"crossref","first-page":"e0147258","DOI":"10.1371\/journal.pone.0147258","article-title":"Interleukin-2 receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis","volume":"11","author":"Gundlach","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.003_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/jamaophthalmol.2017.5466","article-title":"Distinguishing uveitis secondary to sarcoidosis from idiopathic disease: cardiac implications","volume":"136","author":"Han","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09273948.2020.1778733","article-title":"Diagnostic markers in ocular sarcoidosis in A high tb endemic population - a multicentre study","volume":"30","author":"Babu","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.003_bib29","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.003_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajo.2021.01.007","article-title":"Identifying RNA biomarkers and molecular pathways involved in multiple subtypes of uveitis","volume":"226","author":"Rosenbaum","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ccm.2023.08.003_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2020.09.012","article-title":"Revising the diagnosis of idiopathic uveitis by peripheral blood transcriptomics","volume":"222","author":"Rosenbaum","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.003_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yexmp.2015.07.002","article-title":"Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling","volume":"99","author":"Rosenbaum","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.003_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yexmp.2015.01.009","article-title":"Molecular diagnosis of orbital inflammatory disease","volume":"98","author":"Rosenbaum","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.003_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/jamaophthalmol.2015.0726","article-title":"Parallel gene expression changes in sarcoidosis involving the lacrimal gland, orbital tissue, or blood","volume":"133","author":"Rosenbaum","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.003_bib35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/09273948.2020.1861306","article-title":"Peripheral blood transcriptome in patients with sarcoidosis-associated uveitis","volume":"30","author":"Gonzales","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ccm.2023.08.003_bib36","doi-asserted-by":"crossref","first-page":"e67396","DOI":"10.7554\/eLife.67396","article-title":"Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis","volume":"10","author":"Kasper","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ccm.2023.08.003_bib37","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.xops.2021.100010","article-title":"Clinicomolecular identification of concerved and individualized features of granulomatous uveitis","volume":"1","author":"Hassman","year":"2021","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.ccm.2023.08.003_bib38","doi-asserted-by":"crossref","unstructured":"Yang X, Garner LI, Zvyagin IV, et\u00a0al. Autoimmunity-associated T cell receptors recognize HLA-B\u221727-bound peptides. Nature. 2022.612(7941):771-777.","DOI":"10.1038\/s41586-022-05501-7"},{"key":"10.1016\/j.ccm.2023.08.003_bib39","doi-asserted-by":"crossref","unstructured":"Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, et\u00a0al. Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis. Eye (Lond) 2020;34(9):1614-1623.","DOI":"10.1038\/s41433-019-0693-7"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.003_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/09273948.2019.1604974","article-title":"Local cytokine expression profiling in patients with specific autoimmune uveitic entities","volume":"28","author":"Abu El-Asrar","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib41","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1167\/iovs.17-23225","article-title":"Differential CXC and CX3C chemokine expression profiles in aqueous humor of patients with specific endogenous uveitic entities","volume":"59","author":"El-Asrar","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.003_bib42","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1111\/aos.14039","article-title":"Expression of interleukin (IL)-10 family cytokines in aqueous humour of patients with specific endogenous uveitic entities: elevated levels of IL-19 in human leucocyte antigen-B27-associated uveitis","volume":"97","author":"Abu El-Asrar","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.003_bib43","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1167\/iovs.16-19758","article-title":"The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities","volume":"57","author":"Abu El-Asrar","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7\u20138","key":"10.1016\/j.ccm.2023.08.003_bib44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00011-022-01601-2","article-title":"Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis?","volume":"71","author":"De Simone","year":"2022","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.003_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/aos.14993","article-title":"Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies","volume":"100","author":"Schrijver","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib46","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41598-020-59666-0","article-title":"Analysis of inflammatory mediators in the vitreous humor of eyes with pan-uveitis according to aetiological classification","volume":"10","author":"Fukunaga","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1167\/iovs.16-20324","article-title":"Association of high-mobility group box-1 with Th cell-related cytokines in the vitreous of ocular sarcoidosis patients","volume":"58","author":"Takeuchi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.003_bib48","doi-asserted-by":"crossref","first-page":"e014549","DOI":"10.1136\/bmjopen-2016-014549","article-title":"Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study","volume":"7","author":"Maruyama","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10384-013-0288-y","article-title":"Prediction of severe cardiac involvement by fundus lesion in sarcoidosis","volume":"58","author":"Umazume","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ccm.2023.08.003_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2018.10.018","article-title":"Reclassifying idiopathic uveitis: lessons from a tertiary uveitis center","volume":"198","author":"Choi","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13073-016-0344-6","article-title":"Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens","volume":"8","author":"Doan","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.ccm.2023.08.003_bib52","doi-asserted-by":"crossref","first-page":"820","DOI":"10.12688\/f1000research.55090.1","article-title":"Identification of microbial agents in tissue specimens of ocular and periocular sarcoidosis using a metagenomics approach","volume":"10","author":"Shifera","year":"2021","journal-title":"F1000Res"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.003_bib53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.003_bib54","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/jdv.15070","article-title":"Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature","volume":"32","author":"Kluger","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.003_bib55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.003_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12991","article-title":"Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database","volume":"288","author":"Cohen Aubart","year":"2020","journal-title":"J\u00a0Intern Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.003_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCP.0000000000000800","article-title":"Drug-induced sarcoidosis-like reactions","volume":"27","author":"Miedema","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib58","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-distrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s13256-021-03181-x","article-title":"Interferon-induced sarcoidosis with uveitis as the initial symptom: a case report and review of the literature","volume":"15","author":"Kato","year":"2021","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.003_bib60","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/09273948.2020.1850799","article-title":"Drug-induced sarcoid uveitis with biologics","volume":"30","author":"Sobolewska","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.003_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/09273948.2019.1705985","article-title":"Genome-wide association study of ocular sarcoidosis confirms HLA associations and implicates barrier function and autoimmunity in african Americans","volume":"29","author":"Garman","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.003_bib62","doi-asserted-by":"crossref","first-page":"e0202585","DOI":"10.1371\/journal.pone.0202585","article-title":"Age-related differences in the clinical features of ocular sarcoidosis","volume":"13","author":"Takayama","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.003_bib63","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00417-019-04411-1","article-title":"Clinical and etiologic characteristics of de novo uveitis in patients aged 60 years and above: experience of a French tertiary center","volume":"257","author":"Grumet","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.003_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib65","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/art.24533","article-title":"NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain","volume":"60","author":"Rose","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ccm.2023.08.003_bib66","doi-asserted-by":"crossref","first-page":"988862","DOI":"10.3389\/fimmu.2022.988862","article-title":"Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function","volume":"13","author":"Mao","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.003_bib67","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3899\/jrheum.220164","article-title":"Pediatric sarcoidosis: retrospective analysis of biopsy-proven patients","volume":"50","author":"Nott","year":"2022","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib68","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.003_bib69","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10050","key":"10.1016\/j.ccm.2023.08.003_bib70","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib71","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ophtha.2020.10.036","article-title":"Long-term safety and efficacy of adalimumab in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"128","author":"Suhler","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.003_bib72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ajo.2012.10.019","article-title":"Combined depth imaging technique on spectral-domain optical coherence tomography","volume":"155","author":"Barteselli","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib73","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s10792-017-0720-2","article-title":"Diagnostic and therapeutic evaluation of multiple choroidal granulomas in a patient with confirmed sarcoidosis using enhanced depth imaging optical coherence tomography","volume":"38","author":"Ishihara","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.003_bib74","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/09273948.2020.1751210","article-title":"Multimodal imaging in ocular sarcoidosis","volume":"28","author":"Mahendradas","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.003_bib75","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/IAE.0000000000003405","article-title":"Longitudinal follow-up of choroidal granulomas with indocyanine green angiography and optical coherence tomography angiography: a Lesion-Based Analysis","volume":"42","author":"Parrulli","year":"2022","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.003_bib76","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/09273948.2018.1497665","article-title":"New insights on ocular sarcoidosis: an optical coherence tomography angiography study","volume":"27","author":"Cerquaglia","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.003_bib77","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/IAE.0000000000002864","article-title":"Choroidal granulomas visualized by swept-source optical coherence tomography angiography","volume":"41","author":"Pichi","year":"2021","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.003_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12102384","article-title":"Benefits and limitations of OCT-A in the diagnosis and follow-up of posterior intraocular inflammation in current clinical practice: a valuable tool or a deceiver?","volume":"12","author":"Herbort","year":"2022","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.003_bib79","first-page":"1906","article-title":"Quantitative OCT angiography of the retina and choroid in non-ocular sarcoidosis","volume":"26","author":"Balci","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:16:56Z","timestamp":1759454216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272523123000722"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.003","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}